Oral Submucous Fibrosis in Pediatric Patients: A Systematic Review and Protocol for Management

Anuj Jain1, Saumya Taneja2

  • 1Department of Trauma and Emergency Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.

Insights

Oral submucous fibrosis (OSMF) is a growing concern in children, with areca nut chewing identified as the primary cause. This systematic review highlights the urgent need for societal and governmental action to address this dangerous trend in the pediatric population.

Area of Science:

  • Oral Medicine
  • Pediatric Dentistry
  • Oncology

Background:

  • Oral submucous fibrosis (OSMF) is a potentially malignant disorder characterized by juxtaepithelial inflammatory reaction followed by fibroelastic changes.
  • Pediatric cases of OSMF are increasingly reported, necessitating a focused review of existing literature.

Purpose of the Study:

  • To systematically review and evaluate documented cases of oral submucous fibrosis in pediatric patients.
  • To analyze the prevalence, gender distribution, etiology, and clinical presentation of OSMF in children.

Main Methods:

  • A systematic review was conducted adhering to PRISMA guidelines.
  • Five manuscripts focusing on oral submucous fibrosis in pediatric patients were included in the analysis.

Main Results:

  • A total of 10 pediatric cases of OSMF were identified.
  • The youngest patient diagnosed was 2.5 years old, with a noted female preponderance.
  • Areca nut chewing was identified as the consistent etiological factor in all reviewed cases.

Conclusions:

  • The rising incidence of OSMF in the pediatric population poses a significant public health risk.
  • Areca nut chewing, often initiated due to low health consciousness and education, is the primary driver of this condition.
  • Urgent interventions involving parents, schools, and government authorities are crucial to combat this trend.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
489
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
261
Review and Preview01:10

Review and Preview

In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.3K